This Article Full Text Full Text (PDF) All Versions of this Article: 43/5/1103    most recent 01.HYP.0000124668.80811.d3v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abbey-Hosch, S. E. Articles by Potter, L. R. Search for Related Content PubMed PubMed Citation Articles by Abbey-Hosch, S. E. Articles by Potter, L. R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Cardio-renal physiology/pathophysiology Cell signalling/signal transduction Smooth muscle proliferation and differentiation

(Hypertension. 2004;43:1103.)
© 2004 American Heart Association, Inc.

Scientific Contributions

Sphingosine-1-Phosphate Inhibits C-Type Natriuretic Peptide Activation of Guanylyl Cyclase B (GC-B/NPR-B)

From the Departments of Biochemistry, Molecular Biology, and Biophysics (S.E.A., A.N.C., L.R.P.) and Pharmacology (L.R.P.), University of Minnesota, Minneapolis.

Correspondence to Lincoln R. Potter, Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 6–155 Jackson, 321 Church St. SE, Minneapolis, MN 55455. E-mail potter{at}umn.edu

C-type natriuretic peptide (CNP) binds and activates the transmembrane guanylyl cyclase B receptor (NPR-B), which decreases vascular tone and inhibits cell proliferation and migration. In contrast, the bioactive lipid sphingosine-1-phosphate (S1P) elicits the opposite physiological effects. Here, we demonstrate a potent acute inhibitory effect of S1P on NPR-B activity in NIH3T3 fibroblasts and A10 vascular smooth muscle cells. In fibroblasts, S1P reduced CNP-dependent cGMP elevations to the same levels as 10% fetal bovine serum, the most potent NPR-B desensitizing agent known. The reduction was dose-dependent (IC₅₀=0.08 µmol/L) and due to decreased NPR-B activity because CNP-dependent guanylyl cyclase activities were markedly diminished in membranes prepared from S1P-treated cells. Similarly, in A10 cells, S1P inhibition was rapid (t_1/2=2 to 5 minutes), dose-dependent (IC₅₀=0.3 µmol/L S1P), and mediated by a cell surface receptor. The mechanism of the S1P-dependent desensitization in A10 cells did not require NPR-B degradation or protein kinase C activation, but did require elevated calcium concentrations because a nonspecific calcium ionophore also inhibited NPR-B and an intracellular calcium chelator blocked a significant portion of the S1P response. These are the first data demonstrating cross-talk between the natriuretic peptide and S1P signaling systems. They suggest that the effects of S1P on vascular disease and wound healing may be mediated in part through inhibition of NPR-B.

Key Words: vascular diseases • atrial natriuretic factor • cyclic GMP • receptors • natriuretic peptides

This article has been cited by other articles:

				A. M. Richards Natriuretic Peptides: Update on Peptide Release, Bioactivity, and Clinical Use Hypertension, July 1, 2007; 50(1): 25 - 30. [Full Text] [PDF]

				D. Muller, L. Cortes-Dericks, L. T. Budnik, B. Brunswig-Spickenheier, M. Pancratius, R. C. Speth, A. K. Mukhopadhyay, and R. Middendorff Homologous and Lysophosphatidic Acid-Induced Desensitization of the Atrial Natriuretic Peptide Receptor, Guanylyl Cyclase-A, in MA-10 Leydig Cells Endocrinology, June 1, 2006; 147(6): 2974 - 2985. [Abstract] [Full Text] [PDF]

				T. Ozbay, A. Rowan, A. Leon, P. Patel, and M. B. Sewer Cyclic Adenosine 5'-Monophosphate-Dependent Sphingosine-1-Phosphate Biosynthesis Induces Human CYP17 Gene Transcription by Activating Cleavage of Sterol Regulatory Element Binding Protein 1 Endocrinology, March 1, 2006; 147(3): 1427 - 1437. [Abstract] [Full Text] [PDF]

				L. R. Potter, S. Abbey-Hosch, and D. M. Dickey Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions Endocr. Rev., February 1, 2006; 27(1): 47 - 72. [Abstract] [Full Text] [PDF]

				R. Potthast, S. E. Abbey-Hosch, L. K. Antos, J. S. Marchant, M. Kuhn, and L. R. Potter Calcium-dependent Dephosphorylation Mediates the Hyperosmotic and Lysophosphatidic Acid-dependent Inhibition of Natriuretic Peptide Receptor-B/Guanylyl Cyclase-B J. Biol. Chem., November 19, 2004; 279(47): 48513 - 48519. [Abstract] [Full Text] [PDF]